Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases

PLoS Neglected Tropical Diseases

Volumn 3, Issue 8, 2009, Pages

  Morel, Carlos Medicis ^a   Serruya, Suzanne Jacob ^b,c   Penna, Gerson Oliveira ^b   Guimarães, Reinaldo ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b MINISTÉRIO DA SAÚDE   (Brazil)

^c Centro Latinoamericano de Perinatología Salud de la Mujer Y Reproductiva CLAP SMR OPS OMS   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; COMPUTER NETWORK; DATA ANALYSIS SOFTWARE; DATA BASE; DEMOGRAPHY; ENDEMIC DISEASE; FINANCIAL MANAGEMENT; GENERAL ASPECTS OF DISEASE; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; PUBLICATION; STANDARDIZATION;

EID: 70449503645     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000501     Document Type: Article

References (38)

1. WHO Commission on Macroeconomics and Health (2001) WHO Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization. pp 1-200.
2. Médecins Sans Frontières Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group (2001) Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases. Brussels: MSF Access to Essential Medicines Campaign. pp 1-29.
3. Mahoney RT, Morel CM (2006) A global health innovation system (GHIS). Innovation Strategy Today 2: 1-12.
4. Mahoney RT, Morel CM (2006) A Global Health Innovation System (GHIS), Pro-Brook Publishing, volume 3 of Global Forum Update on Research for Health. Combating disease and promoting health. pp 149-156.
5. Moran M (2005) A breakthrough in r&d for neglected diseases: new ways to get the drugs we need. PLoS Med 2: e302.
6. Moran M, Guzman J, Ropars A, McDonald A, Jameson N, et al. (2009) Neglected disease research and development: How much are we really spending? PLoS Med 6: e1000030.
7. Morel CM, Acharya T, Broun D, Dangi A, Elias C, et al. (2005) Health innovation networks to help developing countries address neglected diseases. Science 309: 401-404. (Pubitemid 40994673)
8. Guimarães R, Santos LMP, Angulo-Tuesta A, Serruya SJ (2006) Defining and implementing a national policy for science, technology, and innovation in health: lessons from the Brazilian experience. Cad Saude Publica 22: 1775-1785. (Pubitemid 44342281)
9. Guimarães R, Santos LP (2005) Setting and implementing a health research priority agenda in Brazil, Global Forum for Health Research by Pro-brook Publishing Limited, London, volume 2 of Global Forum Update on Research for Health. pp 96-98.
10. Guimarães R, da Rocha Carvalheiro J, Degrave W (2005) Health technology and innovation: a Brazilian experience, Global Forum for Health Research, chapter 4. Monitoring Financial Flows for Health Research. pp 47-56.
11. Serruya SJ, Guimarães R, de Albuquerque IO, Morel CM (2008) Fostering innovation for global health, Geneva: Global Forum for Health Research, volume 5 of Global Forum Update on Research for Health, chapter Research and innovation in Brazil: The institutional role of the Ministry of Health. pp 24-27.
12. Serruya S, Morel C, Goldbaum M (2007) Research, technological development and innovation in neglected diseases: new strategies adopted by Brazilian funding agencies. In: GFHR Book of Abstracts 11 Beijing[Oct/Nov]. Global Forum for Health Research. 71 p.
13. Newman ME (2001) The structure of scientific collaboration networks. Proc Natl Acad Sci U S A 98: 404-409.
14. Newman ME (2004) Coauthorship networks and patterns of scientific collaboration. Proc Natl Acad Sci U S A 101 Suppl 1: 5200-5205.
15. Guimerà R, Uzzi B, Spiro J, Amaral LA (2005) Team assembly mechanisms determine collaboration network structure and team performance. Science 308: 697-702. (Pubitemid 40594391)
16. Said YH, Wegman EJ, Sharabati WK, Rigsby JT (2008) Social networks of author-coauthor relationships. Comput Stat Data An 52: 2177-2184.
17. González-Alcaide G, Aleixandre-Benavent R, Navarro-Molina C, Valderrama-Zurin JCC (2008) Coauthorship networks and institutional collaboration patterns in reproductive biology. Fertil Steril 90: 941-956. (Pubitemid 351840353)
18. Analytic Technologies (1999) Ucinet 5.0 version 1.00 [computer program]. version 6.205 natick.
19. Scott JP (2000) Social Network Analysis: A Handbook. SAGE Publications.
20. de Nooy W, Mrvar A, Batagelj V (2005) Exploratory Social Network Analysis with Pajek (Structural Analysis in the Social Sciences). Cambridge University Press.
21. Hawe P, Webster C, Shiell A (2004) A glossary of terms for navigating the field of social network analysis. J Epidemiol Community Health 58: 971-975 (Pubitemid 39564192)
22. Hirsch JE (2005) An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A 102: 16569-16572
23. Ioannidis JPA (2008) Measuring co-authorship and networking-adjusted scientific impact. PLoS ONE 3: e2778.
24. Hunter PR (2009) Bibliometrics, research quality, and neglected tropical diseases. Lancet 373: 630-631
25. Gibbons M, Limoges C, Nowotny H, Schwartzman S, Scott P, et al. (1994) The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies. SAGE Publications.
26. Hwang WC, Zhang A, Ramanathan M (2008) Identification of information ow-modulating drug targets: A novel bridging paradigm for drug discovery. Clin Pharmacol Ther 84: 563-572.
27. Csermely P (2008) Creative elements: network-based predictions of active centres in proteins and cellular and social networks. Trends Biochem Sci 33: 569-576
28. Jurberg C (2008) Flawed but fair: Brazil's health system reaches out to the poor. Bull World Health Organ 86: 248-249
29. Aleixandre-Benavent R, González-Alcaide G, Alonso-Arroyo A, Bolaños-Pizarro M, Castelló-Cogollos L, et al. (2008) [Coauthorship networks and institutional collaboration in farmacia hospitalaria.]. Farm Hosp 32: 226-233
30. Valderrama-Zurián JC, González-Alcaide G, Valderrama-Zurián FJ, Aleixandre- Benavent R, Miguel-Dasit A (2007) [Coauthorship networks and institutional collaboration in Revista Española de Cardiología publications]. Rev Esp Cardiol 60: 117-130.
31. Yousefi-Nooraie R, Akbari-Kamrani M, Hanneman RA, Etemadi A (2008) Association between coauthorship network and scientific productivity and impact indicators in academic medical research centers: A case study in Iran. Health Res Policy Syst 6: 9.
32. Henderson DA (1998) Eradication: lessons from the past. Bull World Health Organ 76(Suppl. 2): 7-21.
33. Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL, et al. (2008) Malaria: progress, perils, and prospects for eradication. J Clin Invest 118: 1266-1276.
34. Mills A, Lubell Y, Hanson K (2008) Malaria eradication: the economic, financial and institutional challenge. Malar J 7 Suppl 1: S11.
35. Molyneux DH, Hopkins DR, Zagaria N (2004) Disease eradication, elimination and control: the need for accurate and consistent usage. Trends Parasitol 20: 347-351.
36. da Silva PA, Boffo MMS, de Mattos IG, Silva ABS, Palomino JC, et al. (2006) Comparison of redox and d29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 12: 293-296. (Pubitemid 43379334)
37. Pasqualoto KFM, Ferreira MMC, Santos-Filho OA, Hopfinger AJ (2006) Molecular dynamics simulations of a set of isoniazid derivatives bound to InhA, the enoyl-acp reductase from Mycobacterium tuberculosis. Int J Quantum Chem 106: 2689-2699.
38. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6: 23. (Pubitemid 43793192)